Ventilator Associated Pneumonia Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014556296
Market Monitor Global
Oct-2021
Life Sciences
114 Pages

This report contains market size and forecasts of Ventilator Associated Pneumonia (VAP) Therapeutics in Global, including the following market information:
Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Ventilator Associated Pneumonia (VAP) Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ventilator Associated Pneumonia (VAP) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ventilator Associated Pneumonia (VAP) Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Segment Percentages, By Type, 2020 (%)
Prevention
Physiotherapy
Immunity Therapy

China Ventilator Associated Pneumonia (VAP) Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Ventilator Associated Pneumonia (VAP) Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospitals
Ambulatory Surgical Center
Diagnostic Centers

Global Ventilator Associated Pneumonia (VAP) Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Ventilator Associated Pneumonia (VAP) Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Ventilator Associated Pneumonia (VAP) Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Achaogen
Adenium Biotech
Aridis Pharmaceuticals
AstraZeneca
Bayer
Cardeas Pharma
Destiny Pharma
Dong-A Socio Holdings
Lakewood-Amedex
MedImmune
Meiji Seika Pharma
Merck & Co
Motif Bio
Nabriva Therapeutics
Polyphor
Shionogi & Co
Tetraphase Pharmaceuticals
The Medicines Company
Theravance Biopharma
Wockhardt
Zavante Therapeutics

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Ventilator Associated Pneumonia (VAP) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Overall Market Size
2.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Size: 2021 VS 2027
2.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ventilator Associated Pneumonia (VAP) Therapeutics Players in Global Market
3.2 Top Global Ventilator Associated Pneumonia (VAP) Therapeutics Companies Ranked by Revenue
3.3 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Ventilator Associated Pneumonia (VAP) Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Ventilator Associated Pneumonia (VAP) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ventilator Associated Pneumonia (VAP) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Ventilator Associated Pneumonia (VAP) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Ventilator Associated Pneumonia (VAP) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Prevention
4.1.3 Physiotherapy
4.1.4 Immunity Therapy
4.2 By Type - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Center
5.1.4 Diagnostic Centers
5.2 By Application - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2027
6.3.2 US Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.3.3 Canada Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.3.4 Mexico Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2027
6.4.2 Germany Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4.3 France Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4.4 U.K. Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4.5 Italy Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4.6 Russia Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.4.8 Benelux Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2027
6.5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.5.3 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.5.4 South Korea Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.5.6 India Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2027
6.6.2 Brazil Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.6.3 Argentina Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, 2016-2027
6.7.2 Turkey Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.7.3 Israel Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
6.7.5 UAE Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Achaogen
7.1.1 Achaogen Corporate Summary
7.1.2 Achaogen Business Overview
7.1.3 Achaogen Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.1.4 Achaogen Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.1.5 Achaogen Key News
7.2 Adenium Biotech
7.2.1 Adenium Biotech Corporate Summary
7.2.2 Adenium Biotech Business Overview
7.2.3 Adenium Biotech Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.2.4 Adenium Biotech Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.2.5 Adenium Biotech Key News
7.3 Aridis Pharmaceuticals
7.3.1 Aridis Pharmaceuticals Corporate Summary
7.3.2 Aridis Pharmaceuticals Business Overview
7.3.3 Aridis Pharmaceuticals Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.3.4 Aridis Pharmaceuticals Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.3.5 Aridis Pharmaceuticals Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.4.4 AstraZeneca Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.4.5 AstraZeneca Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.5.4 Bayer Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.5.5 Bayer Key News
7.6 Cardeas Pharma
7.6.1 Cardeas Pharma Corporate Summary
7.6.2 Cardeas Pharma Business Overview
7.6.3 Cardeas Pharma Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.6.4 Cardeas Pharma Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.6.5 Cardeas Pharma Key News
7.7 Destiny Pharma
7.7.1 Destiny Pharma Corporate Summary
7.7.2 Destiny Pharma Business Overview
7.7.3 Destiny Pharma Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.4.4 Destiny Pharma Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.7.5 Destiny Pharma Key News
7.8 Dong-A Socio Holdings
7.8.1 Dong-A Socio Holdings Corporate Summary
7.8.2 Dong-A Socio Holdings Business Overview
7.8.3 Dong-A Socio Holdings Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.8.4 Dong-A Socio Holdings Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.8.5 Dong-A Socio Holdings Key News
7.9 Lakewood-Amedex
7.9.1 Lakewood-Amedex Corporate Summary
7.9.2 Lakewood-Amedex Business Overview
7.9.3 Lakewood-Amedex Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.9.4 Lakewood-Amedex Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.9.5 Lakewood-Amedex Key News
7.10 MedImmune
7.10.1 MedImmune Corporate Summary
7.10.2 MedImmune Business Overview
7.10.3 MedImmune Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.10.4 MedImmune Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.10.5 MedImmune Key News
7.11 Meiji Seika Pharma
7.11.1 Meiji Seika Pharma Corporate Summary
7.11.2 Meiji Seika Pharma Business Overview
7.11.3 Meiji Seika Pharma Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.11.4 Meiji Seika Pharma Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.11.5 Meiji Seika Pharma Key News
7.12 Merck & Co
7.12.1 Merck & Co Corporate Summary
7.12.2 Merck & Co Business Overview
7.12.3 Merck & Co Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.12.4 Merck & Co Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.12.5 Merck & Co Key News
7.13 Motif Bio
7.13.1 Motif Bio Corporate Summary
7.13.2 Motif Bio Business Overview
7.13.3 Motif Bio Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.13.4 Motif Bio Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.13.5 Motif Bio Key News
7.14 Nabriva Therapeutics
7.14.1 Nabriva Therapeutics Corporate Summary
7.14.2 Nabriva Therapeutics Business Overview
7.14.3 Nabriva Therapeutics Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.14.4 Nabriva Therapeutics Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.14.5 Nabriva Therapeutics Key News
7.15 Polyphor
7.15.1 Polyphor Corporate Summary
7.15.2 Polyphor Business Overview
7.15.3 Polyphor Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.15.4 Polyphor Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.15.5 Polyphor Key News
7.16 Shionogi & Co
7.16.1 Shionogi & Co Corporate Summary
7.16.2 Shionogi & Co Business Overview
7.16.3 Shionogi & Co Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.16.4 Shionogi & Co Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.16.5 Shionogi & Co Key News
7.17 Tetraphase Pharmaceuticals
7.17.1 Tetraphase Pharmaceuticals Corporate Summary
7.17.2 Tetraphase Pharmaceuticals Business Overview
7.17.3 Tetraphase Pharmaceuticals Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.17.4 Tetraphase Pharmaceuticals Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.17.5 Tetraphase Pharmaceuticals Key News
7.18 The Medicines Company
7.18.1 The Medicines Company Corporate Summary
7.18.2 The Medicines Company Business Overview
7.18.3 The Medicines Company Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.18.4 The Medicines Company Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.18.5 The Medicines Company Key News
7.19 Theravance Biopharma
7.19.1 Theravance Biopharma Corporate Summary
7.19.2 Theravance Biopharma Business Overview
7.19.3 Theravance Biopharma Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.19.4 Theravance Biopharma Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.19.5 Theravance Biopharma Key News
7.20 Wockhardt
7.20.1 Wockhardt Corporate Summary
7.20.2 Wockhardt Business Overview
7.20.3 Wockhardt Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.20.4 Wockhardt Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.20.5 Wockhardt Key News
7.21 Zavante Therapeutics
7.21.1 Zavante Therapeutics Corporate Summary
7.21.2 Zavante Therapeutics Business Overview
7.21.3 Zavante Therapeutics Ventilator Associated Pneumonia (VAP) Therapeutics Major Product Offerings
7.21.4 Zavante Therapeutics Ventilator Associated Pneumonia (VAP) Therapeutics Revenue in Global (2016-2021)
7.21.5 Zavante Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Ventilator Associated Pneumonia (VAP) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Ventilator Associated Pneumonia (VAP) Therapeutics Market Drivers in Global Market
Table 3. Ventilator Associated Pneumonia (VAP) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Ventilator Associated Pneumonia (VAP) Therapeutics in Global Market
Table 5. Top Ventilator Associated Pneumonia (VAP) Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Ventilator Associated Pneumonia (VAP) Therapeutics Product Type
Table 9. List of Global Tier 1 Ventilator Associated Pneumonia (VAP) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ventilator Associated Pneumonia (VAP) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE